Clinical Trial

Diagnosis of Tuberculosis in Swiss Children

Study acronym: CITRUS
Recruiting
View on ClinicalTrials.gov →
Summary
1. The primary objective is to improve the sensitivity of novel immunodiagnostic tests for detection of TB disease in children. 2. The secondary objective is to determine biomarkers that discriminate children with TB infection and disease.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-02-03; most recent amendment 2024-09-05.
Status change: Not Yet Recruiting → Recruiting 2017-05-16
Trial Details
NCT Number NCT03044509
Lead Sponsor University Children's Hospital Basel
Collaborators: Ospedale Regionale Bellinzona e Valli, Insel Gruppe AG, University Hospital Bern, University of Lausanne Hospitals, University Hospital, Geneva, Luzerner Kantonsspital, Cantonal Hospital of St. Gallen, University Children's Hospital, Zurich, Kantonsspital Aarau
Conditions Tuberculosis, Mycobacterium Tuberculosis
Enrollment 190 participants
Start Date 2017-05-12
Primary Completion 2026-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-19